INTRODUCTION
Chest pain is a common symptom of hypertrophic cardiomyopathy during daily normal activities even despite normal resting ECG and normal coronary angiogram. 1 It appears to be related to myocardial ischemia which may lead to progressive left ventricular remodeling, fibrosis, transmural infarction and focal fibrosis. These morphological changes may produce intractable symptoms and life threatening arrhythmia, thus may lead to syncope and even sudden death. 2 ST-segment depression has been described during resuscitated cardiac arrest and atrial pacing. 3, 4, 5 The prevalence of ST-segment depression and its clinical significance during normal daily activities has not been systematically analysed with Holter monitoring as a noninvasive marker of ischemia.
The aim of this study was to evaluate the chest pain during daily normal activities and its clinical significance of ST-segment depression during Holter monitoring in patients with hypertrophic cardiomyopathy as a non invasive marker of ischaemia.
METHODS
One hundred and Six consecutive patients with hypertrophic cardiomyopathy were evaluated for chest pain with Holter monitoring at Cardiology OPD of Sri Aurobindo Medical College & P.G. Institute between January 2012 to December 2014. Cardiac medication was discontinued for 3 to 5 days prior to Holter monitoring. 22 patients were included who had been receiving amiodarone for >3 months. They were included to avoid bias of selection of low risk patients and were continued because of long half life of amiodarone. 
Baseline Echocardiography (ECG)
Standard 12-leads ECG were perform in all patients using Voltage criteria for left ventricular hypertrophy : Sum of the S wave in V1 plus R wave in V6 > 3.5 mm. Non sustained VT defined as > 3 consecutive ventricular extrasystole at > 100 beats minute -1 lasting for < 30 seconds.
Echocardiography:
2-D and M-mode Echocardiography with conventional measurement techniques were performed.
Holter Monitoring
All patients in our study underwent Holter monitoring for 48 hours during their unrestricted daily activities. Recording were done using Philips 3 channels recording system. Computer assisted analysis was performed using Philips Holter monitoring 1810 series with Digitrak Holter software Zymed Algorithm (3 channels).
Episodes of horizontal or down sloping of ST-segment depression > 1 mm from the baseline for 80 msc from the J point, were taken as positive. Each episode had to be separated from other episode > 1 minute. Recording were not taken for analysis as follows a) atrial fibrillation/ flutter b) LBBB c) persistent RV pacing due to difficulty in defining the isoelectric point and secondary effect on STsegment. Isolated episode of sudden onset offset and excessive baseline wander or artifact were not also considered for analysis. 92 recording were considered for analysis out of 106 recordings.
RESULTS
Altogether 97 episodes of ST-segment depression were detected in 26 patients (M-21, F-5) aged 18-63 years mean age 39.46+12.21 years. 43 episodes were > 2 mm from base linein 14 patient during the recording period. The number of mean episodes per patient was 4 + 6 (range 1-08). The mean number of heart rate during the recording was 139.61+ 15.22 beats minutes -1 in patients with STsegment depression and 134 + 24.68 patients without STsegment depression (Table 1) . There were 18 enrolled patients who were on amiodarone.
ST-segment were analysed of which 10 of them (M-8, F-2) had ST-segment depression during Holter monitoring. 4 out of 10 were aged < 30 years amongst them 3 had ST-segment depression ( Table 2 ). The patients who were taking amiodarone were included in the study so that the sample patient remained representative. Amiodarone may have reduced both the prevalence of chest pain and ST-segment depression in patients of Holter monitoring. 17, 18 In young patients who were on amiodarone were excluded for evaluation of symptoms with ST-Segment depression.
Twenty two analyzed patients out of 92 (23.95%) had ECG finding of LVH according to voltage criteria (Table  3) . There was no relation between LVH and ST changes during Holter monitoring in any group. Coronary Angiography was performed in 12 patients prior to Holter monitoring. 10 raveled normal coronary artery. For out of 10 had ST-segment depression during Holter monitoring. Two Patients with minor coronary artery lesion had no ST-segment depression during recording. 
DISCUSSION
ST-segment depression is a validated marker of ischemia which is used to detect myocardial ischemia with chronic stable angina. [7] [8] [9] [10] [11] [12] The myocardial ischaemia has been investigated by various measures of myocardial perfusion studies. There are various invasive method of detection of myocardial ischemia indirectly by metabolic marker and/or effect. One study showed prevalence of lactate extraction is 70% with hypertrophic cardiomyopathy and exercise induced ST-segment changes and 33% without ST-segment changes. 13 Metabolic evidence of ischemia is found in HCM during ST-segment depression induced by rapid atrial pacing.
14 ST-segment depression also noted preceding sudden cardiac death and /or cardiac arrest. 14, 15 One report demonstrated lower coronary flow reserve in HCM during dipyridamole stress induced ST-segment depressed subject than those without ST-segment change. This may be due to abnormal myocardial metabolism in HCM.
14 Perfusion study such as SPECT with thallium -201 failed to demonstrate an association between reversible thallium abnormalities and a history of typical exertional ischemia in HCM. 19 Coronary sinus lactate concentration as a 'gold standard' of measure of ischemia is limited because it washout quickly and increased during adrenergic stimulation. 20 PET Scan with 13 N-ammonia demonstrated significantly lower coronary flow reserve in HCM patient with chest pain. 20 Mismatch between the uptake of thallium -201 and regional fatty acid metabolism assessed by radio labeled fatty acid analogue BMIPP in HCM is promising as a sensitive clinical marker of ischemia. 21 All these studies are invasive in nature, costly and reliability has not been widely accepted as a marker of myocardial ischemia. Holter monitoring is an established technique for detection myocardial ischemia as a non invasive method and can be done in an outpatient setting.
There are number of potential mechanism of ischemia in the hypertrophic cardiomyopathy: In our study, in young patients with HCM ST-segment depression in commonly associated with exertional chest pain and dyspnea. Myocardial ischemia may be trigger for sudden death in young patients with HCM. 15 In the present study there was no significant association between recognized factors for sudden death such as family history of sudden death, syncope and non sustained VT and STsegment depression in patients with < 30 years of age. Myocardial ischemia is an important possible stimulus for fatal ventricular arrhythmia in sub group of patients. 17 The association between ST-segment changes and symptoms in young patients is a pointer of clinical suspicion that this subgroup has more change to develop myocardial ischemia which may trigger VT and sudden death.
This study was conducted in a across section population who were referred for assessment of their progressive symptoms and necessary investigations and treatment. So the incidence of positive family history and number of patients taking amiodarone are high. This is a small study amongst cross section of population to evaluate ischemia in the HCM with conventional noninvasive Holter monitoring. Larger study based on more sensitive measurement of myocardial flow reserve and other novel metabolic markers of ischemia may evaluate the causes of chest pain in HCM patients.
